Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 3.80
RTIX's Cash to Debt is ranked higher than
67% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. RTIX: 3.80 )
RTIX' s 10-Year Cash to Debt Range
Min: 0.09   Max: No Debt
Current: 3.8

Equity to Asset 0.45
RTIX's Equity to Asset is ranked higher than
52% of the 367 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. RTIX: 0.45 )
RTIX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.9
Current: 0.45

0.3
0.9
F-Score: 4
Z-Score: 0.53
M-Score: -1.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -14.47
RTIX's Operating margin (%) is ranked higher than
55% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. RTIX: -14.47 )
RTIX' s 10-Year Operating margin (%) Range
Min: -76.65   Max: 10.76
Current: -14.47

-76.65
10.76
Net-margin (%) -9.00
RTIX's Net-margin (%) is ranked higher than
57% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. RTIX: -9.00 )
RTIX' s 10-Year Net-margin (%) Range
Min: -77.87   Max: 8.42
Current: -9

-77.87
8.42
ROE (%) -10.60
RTIX's ROE (%) is ranked higher than
57% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 5.93 vs. RTIX: -10.60 )
RTIX' s 10-Year ROE (%) Range
Min: -79.91   Max: 19.17
Current: -10.6

-79.91
19.17
ROA (%) -4.82
RTIX's ROA (%) is ranked higher than
59% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. RTIX: -4.82 )
RTIX' s 10-Year ROA (%) Range
Min: -57.32   Max: 6.1
Current: -4.82

-57.32
6.1
ROC (Joel Greenblatt) (%) -14.95
RTIX's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 13.35 vs. RTIX: -14.95 )
RTIX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -89.77   Max: 16.43
Current: -14.95

-89.77
16.43
Revenue Growth (%) 5.00
RTIX's Revenue Growth (%) is ranked higher than
73% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. RTIX: 5.00 )
RTIX' s 10-Year Revenue Growth (%) Range
Min: -22.5   Max: 6.4
Current: 5

-22.5
6.4
EBITDA Growth (%) -49.00
RTIX's EBITDA Growth (%) is ranked higher than
51% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. RTIX: -49.00 )
RTIX' s 10-Year EBITDA Growth (%) Range
Min: -49   Max: 128.9
Current: -49

-49
128.9
EPS Growth (%) -47.60
RTIX's EPS Growth (%) is ranked higher than
50% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: -1.70 vs. RTIX: -47.60 )
RTIX' s 10-Year EPS Growth (%) Range
Min: -47.6   Max: 223.1
Current: -47.6

-47.6
223.1
» RTIX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

RTIX Guru Trades in Q2 2013

Chuck Royce 1,192,948 sh (+26.18%)
Jim Simons 651,600 sh (+12.27%)
» More
Q3 2013

RTIX Guru Trades in Q3 2013

Chuck Royce 1,792,948 sh (+50.3%)
Jim Simons 568,400 sh (-12.77%)
» More
Q4 2013

RTIX Guru Trades in Q4 2013

Chuck Royce 2,133,948 sh (+19.02%)
Jim Simons 349,000 sh (-38.6%)
» More
Q1 2014

RTIX Guru Trades in Q1 2014

Chuck Royce 2,262,948 sh (+6.05%)
Jim Simons 88,700 sh (-74.58%)
» More
» Details

Insider Trades

Latest Guru Trades with RTIX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Sold Out 0.03%$3.59 - $4.95 $ 4.5212%0
Joel Greenblatt 2012-12-31 Add 70.1%0.01%$4.06 - $4.61 $ 4.525%135102
Mario Gabelli 2012-09-30 Sold Out $3.38 - $4.23 $ 4.5220%0
Joel Greenblatt 2012-03-31 Add 33.62%0.01%$3.45 - $4.47 $ 4.5223%73089
Joel Greenblatt 2011-12-31 New Buy0.03%$3.21 - $4.7 $ 4.529%54700
Mario Gabelli 2011-12-31 Reduce -35.02%$3.21 - $4.7 $ 4.529%28200
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.20
RTIX's P/B is ranked higher than
78% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.46 vs. RTIX: 2.20 )
RTIX' s 10-Year P/B Range
Min: 0.27   Max: 4.88
Current: 2.2

0.27
4.88
P/S 1.17
RTIX's P/S is ranked higher than
85% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. RTIX: 1.17 )
RTIX' s 10-Year P/S Range
Min: 0.62   Max: 4.94
Current: 1.17

0.62
4.94
EV-to-EBIT -8.82
RTIX's EV-to-EBIT is ranked lower than
57% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 44.56 vs. RTIX: -8.82 )
RTIX' s 10-Year EV-to-EBIT Range
Min: 11.3   Max: 2390.3
Current: -8.82

11.3
2390.3
Current Ratio 3.57
RTIX's Current Ratio is ranked higher than
76% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. RTIX: 3.57 )
RTIX' s 10-Year Current Ratio Range
Min: 1   Max: 5.91
Current: 3.57

1
5.91
Quick Ratio 1.54
RTIX's Quick Ratio is ranked higher than
62% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.16 vs. RTIX: 1.54 )
RTIX' s 10-Year Quick Ratio Range
Min: 0.49   Max: 3.07
Current: 1.54

0.49
3.07

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.20
RTIX's Price/Tangible Book is ranked higher than
72% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 5.99 vs. RTIX: 4.20 )
RTIX' s 10-Year Price/Tangible Book Range
Min: 0.97   Max: 6.68
Current: 4.2

0.97
6.68
Price/DCF (Projected) 1.90
RTIX's Price/DCF (Projected) is ranked higher than
90% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. RTIX: 1.90 )
RTIX' s 10-Year Price/DCF (Projected) Range
Min: 0.82   Max: 36.25
Current: 1.9

0.82
36.25
Price/Median PS Value 0.80
RTIX's Price/Median PS Value is ranked higher than
89% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. RTIX: 0.80 )
RTIX' s 10-Year Price/Median PS Value Range
Min: 0.58   Max: 2.74
Current: 0.8

0.58
2.74
Earnings Yield (Greenblatt) 2.10
RTIX's Earnings Yield (Greenblatt) is ranked higher than
60% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. RTIX: 2.10 )
RTIX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 8.8
Current: 2.1

0.1
8.8
Forward Rate of Return (Yacktman) 1.43
RTIX's Forward Rate of Return (Yacktman) is ranked higher than
77% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 0.97 vs. RTIX: 1.43 )
RTIX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.6   Max: 3.8
Current: 1.43

-9.6
3.8

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:RT2.Germany
RTI Surgical Inc, formerly RTI Biologics, Inc., was incorporated in 1997 in Florida. RTI Surgical Inc is a surgical implant company providing surgeons with biologic, metal and synthetic implants. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in approximately 47 countries.
» More Articles for RTIX

Headlines

Articles On GuruFocus.com
Regeneration Technologies Inc. Reports Operating Results (10-Q) Nov 08 2010 
Weekly CFO Buys Highlight: Bank Mutual Corp., Heelys Inc., GenMark Diagnostics Inc., Regeneration Te Sep 19 2010 
Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 
Regeneration Technologies Inc. Reports Operating Results (10-Q) Aug 09 2010 
Regeneration Technologies Inc. Reports Operating Results (10-Q) May 05 2010 
Regeneration Technologies Inc. Reports Operating Results (10-Q) Nov 02 2009 
Regeneration Technologies Inc. Reports Operating Results (10-Q) Aug 04 2009 
RTI Biologics Announces 2009 Second Quarter Results Jul 30 2009 
Regeneration Technologies Inc. Reports Operating Results (10-Q) May 02 2009 
RTI Biologics Announces 2008 Fourth Quarter Earnings and Year End Earnings and Conference Call Feb 11 2009 

More From Our Partners
Greatbatch Meets on Q2 Earnings, Misses on Revenues - Analyst Blog Aug 1 2014 - ZACKS

More From Other Websites
Greatbatch Meets on Q2 Earnings, Misses on Revenues Aug 01 2014
RTI SURGICAL, INC. Files SEC form 10-Q, Quarterly Report Aug 01 2014
Luminex Up on Q2 Earnings Beat, Revs Up on Higher TSP Sales Jul 30 2014
Luminex Corporation (LMNX) Jumps: Stock Adds 8.1% in Session Jul 30 2014
Quality Systems Shares Fall on Lower Q1 Earnings Jul 28 2014
RTI SURGICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
RTI Surgical™ Announces 2014 Second Quarter Results Jul 24 2014
Q2 2014 RTI Surgical, Inc. Earnings Release - Before Market Open Jul 24 2014
RTI Surgical™ Unveils AlloWedge™ Bicortical Bone Wedges and Instrumentation Set at APMA Annual... Jul 23 2014
RTI Surgical Schedules 2014 Second Quarter Earnings Conference Call for July 24, 2014 Jul 17 2014
RTI Surgical™ Unveils PACK Precision Allograft Cartilage Instrument Kit at AOSSM Annual Meeting Jul 10 2014
AngioDynamics' Celerity System Wins FDA Nod for PICC Jun 19 2014
Techne Corporation to Acquire ProteinSimple Jun 18 2014
Edwards Lifesciences' Aortic Heart Valve Gets FDA Approval Jun 17 2014
Varian Medical Systems, Prime Healthcare Ink Technology Deal Jun 16 2014
Navidea (NAVB) Worth Watching: Stock Up 7.3% Jun 12 2014
Masimo Gains on Positive PVI & SpHb Study Data Jun 10 2014
EnteroMedics (ETRM) in Focus: Stock Falls 6.0% in Session Jun 06 2014
FDA Nod for DexCom's G4 PLATINUM System Jun 04 2014
Cryolife Climbs on Dividend Hike May 30 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide